Clinical trial
Bangkok Tenofovir Study, an HIV Pre-exposure Prophylaxis Trial, Bangkok…
NCT00119106 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00119106 |
|---|---|
| Title | Bangkok Tenofovir Study, an HIV Pre-exposure Prophylaxis Trial, Bangkok, Thailand |
| Official title | Study of the Safety and Efficacy of Daily Tenofovir to Prevent HIV Infection Among Injection Drug Users in Bangkok, Thailand |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | Ministry of Health, Thailand Bangkok Metropolitan Administration Medical College and Vajira Hospital |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Tenofovir disoproxil, Placebo |
| Enrollment | 2,413 |
| Start date | Jun 1, 2005 |
| Primary completion | Jul 1, 2013 |
| Completion | Oct 1, 2014 |
| First posted | Jul 13, 2005 |
| Last update posted | Feb 10, 2021 |
| Countries | Thailand |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: